In contrast, GLPs are large hydrophilic incretins that can lower the risk of cardiovascular disease, body weight, suppress glucagon secretion and restore the production of insulin by the body [6, 7, 13, 14]. This evidence concerns the gene GCG and cardiovascular disorder.